CSRXP: PROPOSAL TO LOOSEN PATENT RULES WOULD FURTHER EMPOWER BIG PHARMA TO BLOCK COMPETITION
Lawmakers Should Focus on Bipartisan Solutions to Hold Big Pharma Accountable,… Read More
© 2025 CSRXP- All Rights Reserved
BIG PHARMA WATCH: BIG PHARMA EXPOSED FOR CONTINUING TO HIKE PRICES FASTER THAN RATE OF INFLATION
HHS & CMS Announce New Penalties That Help Hold Brand Name Drug Companies… Read More
ICYMI: THE COST OF BIG PHARMA’S EGREGIOUS PATENT ABUSE ON BRAND NAME INHALERS
Physicians Highlight How Big Pharma Games the System to Boost Profits and… Read More
DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS OVER $40 BILLION IN JUST ONE YEAR
New Analysis Highlights Urgency to Hold Big Pharma Accountable for Egregious… Read More
DOSE OF REALITY: BIG PHARMA TAX AVOIDANCE PRACTICES COME UNDER SCRUTINY IN SENATE FINANCE HEARING
Report Finds Big Pharma Games the System to Avoid Paying U.S. Taxes While… Read More
THEY SAID IT! LAWMAKERS SLAM BIG PHARMA CEOS FOR EGREGIOUS PRICING OF BRAND NAME INSULINS
Brand Name Drug Giants Refuse to Rule Out Future Insulin Price Hikes On… Read More
CSRXP COMMENDS HELP COMMITTEE FOR ADVANCING BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
Senate Panel Passes Bills to Increase Competition and Increase List Price… Read More
CSRXP: SENATORS HAVE OPPORTUNITY TO PASS BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
U.S. Senate HELP Committee Should Advance Legislation to Boost Competition and… Read More
DOSE OF REALITY: SENATORS MUST HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS INSULIN PRICING PRACTICES
Lawmakers Have Opportunity to Grill Big Pharma Executives on Tactics Like… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, MODERNA, ELI LILLY, NOVARTIS, GLAXOSMITHKLINE, ROCHE, AMGEN
Brand Name Drug Companies Continue to Hike Prices and Post Record Profits… Read More
CSRXP: MODERNA BRAZENLY IGNORES OUTRAGE BY MOVING AHEAD WITH EGREGIOUS VACCINE PRICE HIKE
Nearly 500 Percent Price Increase on Vaccine Developed with Taxpayer… Read More
BIG PHARMA EARNINGS WATCH: MERCK, SANOFI, BRISTOL MYERS SQUIBB, ABBVIE AND ASTRAZENECA
More Big Pharma Giants Surpass Wall Street Expectations, Buoyed By Egregious… Read More